RASA4B: A Potential Drug Target and Biomarker (G100271927)

Target Name: RASA4B

NCBI ID: G100271927

RASA4B

Other Name(s): Putative Ras GTPase-activating protein 4B | putative Ras GTPase-activating protein 4B | RAS p21 protein activator 4B | Ras GTPase-activating protein 4B | RAS4B_HUMAN

RASA4B: A Potential Drug Target and Biomarker

Ras-associated protein 4B (RASA4B) is a protein that is expressed in various tissues and cell types in the body. It is a key regulator of cell signaling pathways, including the RAS/MAPK pathway. This pathway is involved in various cellular processes, including cell growth, differentiation, and survival. RASA4B has also been shown to play a role in cancer progression.

Recent studies have identified RASA4B as a potential drug target. By inhibiting the activity of RASA4B, researchers have shown that they can reduce the growth and spread of cancer cells. This suggests that RASA4B may be a useful target for cancer treatment.

In addition to its potential as a cancer drug, RASA4B has also been identified as a biomarker. By measuring the level of RASA4B in cancer cells, researchers can monitor the effectiveness of a treatment. This suggests that RASA4B may be a useful biomarker for cancer diagnosis and treatment.

The RASA4B pathway is involved in many cellular processes in the body. It is a key regulator of cell signaling pathways, including the RAS/MAPK pathway. This pathway is involved in various cellular processes, including cell growth, differentiation, and survival. RASA4B is a key component of this pathway and plays a role in regulating the activity of various proteins that are involved in cell signaling.

In cancer cells, the RASA4B pathway is often activated and out of control. This allows cancer cells to grow and spread rapidly. By inhibiting the activity of RASA4B, researchers have shown that they can reduce the growth and spread of cancer cells. This suggests that RASA4B may be a useful target for cancer treatment.

In addition to its potential as a cancer drug, RASA4B has also been identified as a biomarker. By measuring the level of RASA4B in cancer cells, researchers can monitor the effectiveness of a treatment. This suggests that RASA4B may be a useful biomarker for cancer diagnosis and treatment.

Overall, RASA4B is a protein that has the potential to be a drug target and biomarker in cancer treatment. Further research is needed to fully understand its role in cancer biology and to develop effective treatments.

Protein Name: RAS P21 Protein Activator 4B

Functions: Ca(2+)-dependent Ras GTPase-activating protein, that may play a role in the Ras-MAPK pathway

The "RASA4B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RASA4B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets